Sana Biotechnology: Early-Stage Biotech With Promising Allogeneic CAR-T Pipeline
c Christoph Burgstedt Thesis Sana Biotechnology (NASDAQ:SANA) is a biotech company in the early clinical-stage, focused on the development of engineered allogeneic cells (genetically-modified cells from healthy donors) for the treatment of diseases with …